These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

592 related items for PubMed ID: 26822305

  • 1. Loss of Mrp1 Potentiates Doxorubicin-Induced Cytotoxicity in Neonatal Mouse Cardiomyocytes and Cardiac Fibroblasts.
    Zhang W, St Clair D, Butterfield A, Vore M.
    Toxicol Sci; 2016 May; 151(1):44-56. PubMed ID: 26822305
    [Abstract] [Full Text] [Related]

  • 2. Elevated glutathione is not sufficient to protect against doxorubicin-induced nuclear damage in heart in multidrug resistance-associated protein 1 (Mrp1/Abcc1) null mice.
    Deng J, Coy D, Zhang W, Sunkara M, Morris AJ, Wang C, Chaiswing L, St Clair D, Vore M, Jungsuwadee P.
    J Pharmacol Exp Ther; 2015 Nov; 355(2):272-9. PubMed ID: 26354996
    [Abstract] [Full Text] [Related]

  • 3. Loss of multidrug resistance-associated protein 1 potentiates chronic doxorubicin-induced cardiac dysfunction in mice.
    Zhang W, Deng J, Sunkara M, Morris AJ, Wang C, St Clair D, Vore M.
    J Pharmacol Exp Ther; 2015 Nov; 355(2):280-7. PubMed ID: 26354995
    [Abstract] [Full Text] [Related]

  • 4. Doxorubicin triggers bioenergetic failure and p53 activation in mouse stem cell-derived cardiomyocytes.
    Cunha-Oliveira T, Ferreira LL, Coelho AR, Deus CM, Oliveira PJ.
    Toxicol Appl Pharmacol; 2018 Jun 01; 348():1-13. PubMed ID: 29653124
    [Abstract] [Full Text] [Related]

  • 5. Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro.
    Mukhopadhyay P, Rajesh M, Bátkai S, Kashiwaya Y, Haskó G, Liaudet L, Szabó C, Pacher P.
    Am J Physiol Heart Circ Physiol; 2009 May 01; 296(5):H1466-83. PubMed ID: 19286953
    [Abstract] [Full Text] [Related]

  • 6. Over-expression of calpastatin aggravates cardiotoxicity induced by doxorubicin.
    Wang Y, Zheng D, Wei M, Ma J, Yu Y, Chen R, Lacefield JC, Xu H, Peng T.
    Cardiovasc Res; 2013 Jun 01; 98(3):381-90. PubMed ID: 23455548
    [Abstract] [Full Text] [Related]

  • 7. Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy.
    van Almen GC, Swinnen M, Carai P, Verhesen W, Cleutjens JP, D'hooge J, Verheyen FK, Pinto YM, Schroen B, Carmeliet P, Heymans S.
    J Mol Cell Cardiol; 2011 Sep 01; 51(3):318-28. PubMed ID: 21624372
    [Abstract] [Full Text] [Related]

  • 8. Rac1 signalling mediates doxorubicin-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathways.
    Ma J, Wang Y, Zheng D, Wei M, Xu H, Peng T.
    Cardiovasc Res; 2013 Jan 01; 97(1):77-87. PubMed ID: 23027656
    [Abstract] [Full Text] [Related]

  • 9. Human Amnion Membrane Proteins Prevent Doxorubicin-Induced Oxidative Stress Injury and Apoptosis in Rat H9c2 Cardiomyocytes.
    Faridvand Y, Haddadi P, Vahedian V, Nozari S, Nejabati HR, Pezeshkian M, Afrasiabi A, Safaie N, Jodati A, Nouri M.
    Cardiovasc Toxicol; 2020 Aug 01; 20(4):370-379. PubMed ID: 32086724
    [Abstract] [Full Text] [Related]

  • 10. Sodium thiosulfate prevents doxorubicin-induced DNA damage and apoptosis in cardiomyocytes in mice.
    Mizuta Y, Tokuda K, Guo J, Zhang S, Narahara S, Kawano T, Murata M, Yamaura K, Hoka S, Hashizume M, Akahoshi T.
    Life Sci; 2020 Sep 15; 257():118074. PubMed ID: 32673667
    [Abstract] [Full Text] [Related]

  • 11. Targeted disruption of p53 attenuates doxorubicin-induced cardiac toxicity in mice.
    Shizukuda Y, Matoba S, Mian OY, Nguyen T, Hwang PM.
    Mol Cell Biochem; 2005 May 15; 273(1-2):25-32. PubMed ID: 16013437
    [Abstract] [Full Text] [Related]

  • 12. Exercise during pregnancy decreases doxorubicin-induced cardiotoxic effects on neonatal hearts.
    Brito VB, Nascimento LV, Nunes RB, Moura DJ, Lago PD, Saffi J.
    Toxicology; 2016 Aug 10; 368-369():46-57. PubMed ID: 27565713
    [Abstract] [Full Text] [Related]

  • 13. Influence of PARP-1 inhibition in the cardiotoxicity of the topoisomerase 2 inhibitors doxorubicin and mitoxantrone.
    Damiani RM, Moura DJ, Viau CM, Brito V, Morás AM, Henriques JAP, Saffi J.
    Toxicol In Vitro; 2018 Oct 10; 52():203-213. PubMed ID: 29913208
    [Abstract] [Full Text] [Related]

  • 14. Insulin-like growth factor II receptor-α is a novel stress-inducible contributor to cardiac damage underpinning doxorubicin-induced oxidative stress and perturbed mitochondrial autophagy.
    Pandey S, Kuo WW, Shen CY, Yeh YL, Ho TJ, Chen RJ, Chang RL, Pai PY, Viswanadha VP, Huang CY, Huang CY.
    Am J Physiol Cell Physiol; 2019 Aug 01; 317(2):C235-C243. PubMed ID: 31116582
    [Abstract] [Full Text] [Related]

  • 15. Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone.
    Damiani RM, Moura DJ, Viau CM, Caceres RA, Henriques JAP, Saffi J.
    Arch Toxicol; 2016 Sep 01; 90(9):2063-2076. PubMed ID: 27342245
    [Abstract] [Full Text] [Related]

  • 16. Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress.
    Zhao D, Xue C, Li J, Feng K, Zeng P, Chen Y, Duan Y, Zhang S, Li X, Han J, Yang X.
    Biochem Biophys Res Commun; 2020 Dec 10; 533(3):304-312. PubMed ID: 32958254
    [Abstract] [Full Text] [Related]

  • 17. Cardamonin protects against doxorubicin-induced cardiotoxicity in mice by restraining oxidative stress and inflammation associated with Nrf2 signaling.
    Qi W, Boliang W, Xiaoxi T, Guoqiang F, Jianbo X, Gang W.
    Biomed Pharmacother; 2020 Feb 10; 122():109547. PubMed ID: 31918264
    [Abstract] [Full Text] [Related]

  • 18. Oxidative stress on cardiotoxicity after treatment with single and multiple doses of doxorubicin.
    Segredo MP, Salvadori DM, Rocha NS, Moretto FC, Correa CR, Camargo EA, de Almeida DC, Reis RA, Freire CM, Braz MG, Tang G, Matsubara LS, Matsubara BB, Yeum KJ, Ferreira AL.
    Hum Exp Toxicol; 2014 Jul 10; 33(7):748-60. PubMed ID: 24275640
    [Abstract] [Full Text] [Related]

  • 19. N-acetylcysteine amide decreases oxidative stress but not cell death induced by doxorubicin in H9c2 cardiomyocytes.
    Shi R, Huang CC, Aronstam RS, Ercal N, Martin A, Huang YW.
    BMC Pharmacol; 2009 Apr 15; 9():7. PubMed ID: 19368719
    [Abstract] [Full Text] [Related]

  • 20. Cardiomyocytes, cardiac endothelial cells and fibroblasts contribute to anthracycline-induced cardiac injury through RAS-homologous small GTPases RAC1 and CDC42.
    Kücük P, Abbey L, Schmitt J, Henninger C, Fritz G.
    Pharmacol Res; 2024 May 15; 203():107165. PubMed ID: 38561112
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.